These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1987945

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma.
    Baldwin JJ, Ponticello GS, Anderson PS, Christy ME, Murcko MA, Randall WC, Schwam H, Sugrue MF, Springer JP, Gautheron P.
    J Med Chem; 1989 Dec; 32(12):2510-3. PubMed ID: 2585439
    [No Abstract] [Full Text] [Related]

  • 5. Topical carbonic anhydrase inhibitors.
    Kass MA.
    Am J Ophthalmol; 1989 Mar 15; 107(3):280-2. PubMed ID: 2923154
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A topical carbonic anhydrase inhibitor finally arrives.
    Palmberg P.
    Arch Ophthalmol; 1995 Aug 15; 113(8):985-6. PubMed ID: 7639673
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous beagles.
    King TC, Gum GG, Gelatt KN.
    Am J Vet Res; 1991 Dec 15; 52(12):2067-70. PubMed ID: 1789524
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.
    Gugleta K.
    Curr Med Res Opin; 2010 Jun 15; 26(6):1255-67. PubMed ID: 20350146
    [Abstract] [Full Text] [Related]

  • 13. The effectiveness and safety of dorzolamide 2% in addition to multiple topical antiglaucoma medications.
    Le HH, Chang MR, Cheng Q, Lee DA, Hartenbaum D.
    J Ocul Pharmacol Ther; 1999 Aug 15; 15(4):305-12. PubMed ID: 10463869
    [Abstract] [Full Text] [Related]

  • 14. [Glaucoma: an ocular blood flow disorder?].
    Recker K.
    Ophthalmologe; 2003 Feb 15; 100(2):2 p following 174. PubMed ID: 12650170
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological advances in the treatment of glaucoma.
    Serle JB.
    Drugs Aging; 1994 Sep 15; 5(3):156-70. PubMed ID: 7803944
    [Abstract] [Full Text] [Related]

  • 16. [Glaucoma. Current problems. Continuing education courses at the Ophthalmologic Clinic of the Eppendorf University Hospital, 9 December 1995].
    Klin Monbl Augenheilkd; 1996 Feb 15; 208(2 Suppl):1-4. PubMed ID: 9022390
    [No Abstract] [Full Text] [Related]

  • 17. Central corneal thickness.
    Hustead JD.
    Arch Ophthalmol; 1998 Sep 15; 116(9):1263. PubMed ID: 9747703
    [No Abstract] [Full Text] [Related]

  • 18. Economic evaluation of dorzolamide vs. pilocarpine for primary open-angle glaucoma.
    Rocchi A, Tingey D.
    Can J Ophthalmol; 1997 Oct 15; 32(6):414-8. PubMed ID: 9363347
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Modern anti-glaucoma drugs and their secondary effects].
    Mermoud A.
    Rev Med Suisse Romande; 1998 Nov 15; 118(11):937-40. PubMed ID: 9865122
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.